Cover Image
Market Research Report

Global Prophylactic Human Vaccines Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 797830
Published Content info 102 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Prophylactic Human Vaccines Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 102 Pages
Description

In 2018, the global Prophylactic Human Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prophylactic Human Vaccines development in United States, Europe and China.

The key players covered in this study

  • ALK
  • Altimmune
  • Bavarian Nordic
  • BiondVax Pharmaceuticals
  • Bharat Biotech International
  • GlaxoSmithKline
  • Hualan Biological Engineering
  • Janssen Pharmaceuticals
  • MedImmune
  • Merck
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India
  • Shanghai BravoBio
  • Seqirus
  • SK Chemicals
  • Takeda Pharmaceutical Company
  • Zydus Cadila

Market segment by Type, the product can be split into

  • Type I
  • Type II

Market segment by Application, split into

  • Pediatric Prophylactic Vaccines
  • Adult Prophylactic Vaccines

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players.
  • To present the Prophylactic Human Vaccines development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Prophylactic Human Vaccines are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Prophylactic Human Vaccines Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Type I
    • 1.4.3 Type II
  • 1.5 Market by Application
    • 1.5.1 Global Prophylactic Human Vaccines Market Share by Application (2014-2025)
    • 1.5.2 Pediatric Prophylactic Vaccines
    • 1.5.3 Adult Prophylactic Vaccines
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Prophylactic Human Vaccines Market Size
  • 2.2 Prophylactic Human Vaccines Growth Trends by Regions
    • 2.2.1 Prophylactic Human Vaccines Market Size by Regions (2014-2025)
    • 2.2.2 Prophylactic Human Vaccines Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Prophylactic Human Vaccines Market Size by Manufacturers
    • 3.1.1 Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Prophylactic Human Vaccines Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Prophylactic Human Vaccines Market Concentration Ratio (CR5 and HHI)
  • 3.2 Prophylactic Human Vaccines Key Players Head office and Area Served
  • 3.3 Key Players Prophylactic Human Vaccines Product/Solution/Service
  • 3.4 Date of Enter into Prophylactic Human Vaccines Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Prophylactic Human Vaccines Market Size by Type (2014-2019)
  • 4.2 Global Prophylactic Human Vaccines Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Prophylactic Human Vaccines Market Size (2014-2019)
  • 5.2 Prophylactic Human Vaccines Key Players in United States
  • 5.3 United States Prophylactic Human Vaccines Market Size by Type
  • 5.4 United States Prophylactic Human Vaccines Market Size by Application

6 Europe

  • 6.1 Europe Prophylactic Human Vaccines Market Size (2014-2019)
  • 6.2 Prophylactic Human Vaccines Key Players in Europe
  • 6.3 Europe Prophylactic Human Vaccines Market Size by Type
  • 6.4 Europe Prophylactic Human Vaccines Market Size by Application

7 China

  • 7.1 China Prophylactic Human Vaccines Market Size (2014-2019)
  • 7.2 Prophylactic Human Vaccines Key Players in China
  • 7.3 China Prophylactic Human Vaccines Market Size by Type
  • 7.4 China Prophylactic Human Vaccines Market Size by Application

8 Japan

  • 8.1 Japan Prophylactic Human Vaccines Market Size (2014-2019)
  • 8.2 Prophylactic Human Vaccines Key Players in Japan
  • 8.3 Japan Prophylactic Human Vaccines Market Size by Type
  • 8.4 Japan Prophylactic Human Vaccines Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Prophylactic Human Vaccines Market Size (2014-2019)
  • 9.2 Prophylactic Human Vaccines Key Players in Southeast Asia
  • 9.3 Southeast Asia Prophylactic Human Vaccines Market Size by Type
  • 9.4 Southeast Asia Prophylactic Human Vaccines Market Size by Application

10 India

  • 10.1 India Prophylactic Human Vaccines Market Size (2014-2019)
  • 10.2 Prophylactic Human Vaccines Key Players in India
  • 10.3 India Prophylactic Human Vaccines Market Size by Type
  • 10.4 India Prophylactic Human Vaccines Market Size by Application

11 Central & South America

  • 11.1 Central & South America Prophylactic Human Vaccines Market Size (2014-2019)
  • 11.2 Prophylactic Human Vaccines Key Players in Central & South America
  • 11.3 Central & South America Prophylactic Human Vaccines Market Size by Type
  • 11.4 Central & South America Prophylactic Human Vaccines Market Size by Application

12 International Players Profiles

  • 12.1 ALK
    • 12.1.1 ALK Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Prophylactic Human Vaccines Introduction
    • 12.1.4 ALK Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.1.5 ALK Recent Development
  • 12.2 Altimmune
    • 12.2.1 Altimmune Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Prophylactic Human Vaccines Introduction
    • 12.2.4 Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.2.5 Altimmune Recent Development
  • 12.3 Bavarian Nordic
    • 12.3.1 Bavarian Nordic Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Prophylactic Human Vaccines Introduction
    • 12.3.4 Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.3.5 Bavarian Nordic Recent Development
  • 12.4 BiondVax Pharmaceuticals
    • 12.4.1 BiondVax Pharmaceuticals Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Prophylactic Human Vaccines Introduction
    • 12.4.4 BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.4.5 BiondVax Pharmaceuticals Recent Development
  • 12.5 Bharat Biotech International
    • 12.5.1 Bharat Biotech International Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Prophylactic Human Vaccines Introduction
    • 12.5.4 Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.5.5 Bharat Biotech International Recent Development
  • 12.6 GlaxoSmithKline
    • 12.6.1 GlaxoSmithKline Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Prophylactic Human Vaccines Introduction
    • 12.6.4 GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.6.5 GlaxoSmithKline Recent Development
  • 12.7 Hualan Biological Engineering
    • 12.7.1 Hualan Biological Engineering Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Prophylactic Human Vaccines Introduction
    • 12.7.4 Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.7.5 Hualan Biological Engineering Recent Development
  • 12.8 Janssen Pharmaceuticals
    • 12.8.1 Janssen Pharmaceuticals Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Prophylactic Human Vaccines Introduction
    • 12.8.4 Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.8.5 Janssen Pharmaceuticals Recent Development
  • 12.9 MedImmune
    • 12.9.1 MedImmune Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Prophylactic Human Vaccines Introduction
    • 12.9.4 MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.9.5 MedImmune Recent Development
  • 12.10 Merck
    • 12.10.1 Merck Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Prophylactic Human Vaccines Introduction
    • 12.10.4 Merck Revenue in Prophylactic Human Vaccines Business (2014-2019)
    • 12.10.5 Merck Recent Development
  • 12.11 Pfizer
  • 12.12 Sanofi Pasteur
  • 12.13 Serum Institute of India
  • 12.14 Shanghai BravoBio
  • 12.15 Seqirus
  • 12.16 SK Chemicals
  • 12.17 Takeda Pharmaceutical Company
  • 12.18 Zydus Cadila

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table Prophylactic Human Vaccines Key Market Segments
  • Table Key Players Prophylactic Human Vaccines Covered
  • Table Global Prophylactic Human Vaccines Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Prophylactic Human Vaccines Market Size Market Share by Type 2014-2025
  • Figure Type I Figures
  • Table Key Players of Type I
  • Figure Type II Figures
  • Table Key Players of Type II
  • Table Global Prophylactic Human Vaccines Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Pediatric Prophylactic Vaccines Case Studies
  • Figure Adult Prophylactic Vaccines Case Studies
  • Figure Prophylactic Human Vaccines Report Years Considered
  • Table Global Prophylactic Human Vaccines Market Size 2014-2025 (Million US$)
  • Figure Global Prophylactic Human Vaccines Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Prophylactic Human Vaccines Market Size by Regions 2014-2025 (Million US$)
  • Table Global Prophylactic Human Vaccines Market Size by Regions 2014-2019 (Million US$)
  • Table Global Prophylactic Human Vaccines Market Share by Regions 2014-2019
  • Figure Global Prophylactic Human Vaccines Market Share by Regions 2014-2019
  • Figure Global Prophylactic Human Vaccines Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Prophylactic Human Vaccines Market Share by Manufacturers (2014-2019)
  • Figure Global Prophylactic Human Vaccines Market Share by Manufacturers in 2018
  • Table Global Prophylactic Human Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Prophylactic Human Vaccines Product/Solution/Service
  • Table Date of Enter into Prophylactic Human Vaccines Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
  • Table Global Prophylactic Human Vaccines Market Size Share by Type (2014-2019)
  • Figure Global Prophylactic Human Vaccines Market Size Market Share by Type (2014-2019)
  • Table Global Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table Global Prophylactic Human Vaccines Market Size Share by Application (2014-2019)
  • Figure Global Prophylactic Human Vaccines Market Size Market Share by Application (2014-2019)
  • Figure Global Prophylactic Human Vaccines Revenue Market Share by Application in 2018
  • Figure United States Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
  • Table United States Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
  • Table United States Key Players Prophylactic Human Vaccines Market Share (2018-2019)
  • Table United States Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
  • Table United States Prophylactic Human Vaccines Market Share by Type (2014-2019)
  • Table United States Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table United States Prophylactic Human Vaccines Market Share by Application (2014-2019)
  • Figure Europe Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Prophylactic Human Vaccines Market Share (2018-2019)
  • Table Europe Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
  • Table Europe Prophylactic Human Vaccines Market Share by Type (2014-2019)
  • Table Europe Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table Europe Prophylactic Human Vaccines Market Share by Application (2014-2019)
  • Figure China Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
  • Table China Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
  • Table China Key Players Prophylactic Human Vaccines Market Share (2018-2019)
  • Table China Prophylactic Human Vaccines Market Size by Type (2014-20189) (Million US$)
  • Table China Prophylactic Human Vaccines Market Share by Type (2014-2019)
  • Table China Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table China Prophylactic Human Vaccines Market Share by Application (2014-2019)
  • Figure Japan Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Prophylactic Human Vaccines Market Share (2018-2019)
  • Table Japan Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
  • Table Japan Prophylactic Human Vaccines Market Share by Type (2014-2019)
  • Table Japan Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table Japan Prophylactic Human Vaccines Market Share by Application (2014-2019)
  • Figure Southeast Asia Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Prophylactic Human Vaccines Market Share (2018-2019)
  • Table Southeast Asia Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Prophylactic Human Vaccines Market Share by Type (2014-2019)
  • Table Southeast Asia Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Prophylactic Human Vaccines Market Share by Application (2014-2019)
  • Figure India Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
  • Table India Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
  • Table India Key Players Prophylactic Human Vaccines Market Share (2018-2019)
  • Table India Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
  • Table India Prophylactic Human Vaccines Market Share by Type (2014-2019)
  • Table India Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table India Prophylactic Human Vaccines Market Share by Application (2014-2019)
  • Figure Central & South America Prophylactic Human Vaccines Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Prophylactic Human Vaccines Market Share (2018-2019)
  • Table Central & South America Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Prophylactic Human Vaccines Market Share by Type (2014-2019)
  • Table Central & South America Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Prophylactic Human Vaccines Market Share by Application (2014-2019)
  • Table ALK Company Details
  • Table ALK Revenue in Prophylactic Human Vaccines Business (2014-2019) (Million US$)
  • Figure ALK Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table ALK Recent Development
  • Table Altimmune Company Details
  • Table Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure Altimmune Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table Altimmune Recent Development
  • Table Bavarian Nordic Company Details
  • Table Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure Bavarian Nordic Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table Bavarian Nordic Recent Development
  • Table BiondVax Pharmaceuticals Company Details
  • Table BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure BiondVax Pharmaceuticals Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table BiondVax Pharmaceuticals Recent Development
  • Table Bharat Biotech International Company Details
  • Table Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure Bharat Biotech International Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table Bharat Biotech International Recent Development
  • Table GlaxoSmithKline Company Details
  • Table GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure GlaxoSmithKline Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table GlaxoSmithKline Recent Development
  • Table Hualan Biological Engineering Company Details
  • Table Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure Hualan Biological Engineering Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table Hualan Biological Engineering Recent Development
  • Table Janssen Pharmaceuticals Company Details
  • Table Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure Janssen Pharmaceuticals Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table Janssen Pharmaceuticals Recent Development
  • Table MedImmune Company Details
  • Table MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure MedImmune Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table MedImmune Recent Development
  • Table Merck Company Details
  • Table Merck Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$)
  • Figure Merck Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019)
  • Table Merck Recent Development
  • Table Pfizer Company Details
  • Table Sanofi Pasteur Company Details
  • Table Serum Institute of India Company Details
  • Table Shanghai BravoBio Company Details
  • Table Seqirus Company Details
  • Table SK Chemicals Company Details
  • Table Takeda Pharmaceutical Company Company Details
  • Table Zydus Cadila Company Details
  • Table Global Prophylactic Human Vaccines Market Size by Regions (Million US$) 2019-2025
  • Figure Global Prophylactic Human Vaccines Market Size Share by Regions (2019-2025)
  • Figure Global Prophylactic Human Vaccines Market Size Share by Regions in 2025
  • Figure United States Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
  • Figure China Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
  • Figure India Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD)
  • Table Global Prophylactic Human Vaccines Market Size by Product (2019-2025) (Million US$)
  • Figure Global Prophylactic Human Vaccines Market Size by Product (2019-2025)
  • Figure Global Prophylactic Human Vaccines Market Size by Product in 2025
  • Table Global Prophylactic Human Vaccines Market Size by Application (2019-2025) (Million US$)
  • Figure Global Prophylactic Human Vaccines Market Size by Application (2019-2025)
  • Figure Global Prophylactic Human Vaccines Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top